Neurotoxicity Syndromes
Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.
Subtype terms (7)
More specific conditions that are subtypes of Neurotoxicity Syndromes in the MeSH hierarchy.
- Akathisia, Drug-Induced
3 drugs (2 approved, 1 experimental)
- Alcohol-Induced Disorders, Nervous System
1 drug approved
- Botulism
11 drugs (6 approved, 5 experimental)
- Dyskinesia, Drug-Induced
13 drugs (8 approved, 5 experimental)
- Heavy Metal Poisoning, Nervous System
- MPTP Poisoning
- Neuroleptic Malignant Syndrome
Drugs by status
Phase 3 trials (5)
Phase 2 trials (6)
Phase 1 trials (2)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (45)
- Merck
- Sanofi
- BioNumerik Pharmaceuticals, Inc.
- National Cancer Institute (NCI)
- Cancer and Leukemia Group B (CALGB)
- University of London
- Harvard University
- Eastern Cooperative Oncology Group
- Gynecologic Oncology Group
- Nanjing Medical University
- NRG Oncology
- New York University
- Northwestern University
- North Central Cancer Treatment Group
- Oregon Health and Science University
- Radiation Therapy Oncology Group
- Southwest Oncology Group
- Thomas Jefferson University
- University of Groningen
- University of Melbourne
- University of Michigan
- University of Rochester
- University of South Florida
- University of Toronto
- Wake Forest University
- University of Virginia
- Mayo Clinic
- University of California, San Diego
- Uppsala University
- Bangladesh Medical University
- +15 more
Organization Involved with Phase 2 Indications (31)
- Swedish Orphan Biovitrum
- Jazz Pharmaceuticals
- Gilead Sciences
- Cancer Research UK
- Cornell University
- ECOG-ACRIN Cancer Research Group
- Temple University
- University of Washington
- Herbert Irving Comprehensive Cancer Center
- Indiana University
- Qingdao University
- University of Leeds
- University of Alberta
- West Virginia University
- Asociación Oncosur
- Capital Medical University
- Columbia University
- Peking University
- University of Calgary
- University of California, San Francisco
- Tsinghua University
- Institut de Cancerologie de l'Ouest Paul Papin
- Weifang People's Hospital
- Curie Institute
- City of Hope National Medical Center
- Hospital Universitario Infanta Leonor
- Hospital Universitario de Fuenlabrada
- Henan Medical University
- ARCAGY-GINECO
- People's Liberation Army of China
- +1 more
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (6)